Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
31
1
2
3
4
5
6
8
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
31
1
2
3
Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the 37th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Gerald Herman, CFO [...]
Allergan to Present at the 37th Annual J.P. Morgan Healthcare Conference
2019-01-07    
3:30 pm
Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, [...]
Johnson & Johnson to Participate in 37th Annual JP Morgan Health Care Conference
2019-01-07    
3:30 pm
Johnson & Johnson (NYSE: JNJ) will participate in the 37th Annual JP Morgan Health Care Conference on Monday, Jan. 7th, at the Westin St. Francis in San Francisco.  Joseph J. [...]
Halozyme Therapeutics To Present At The 37th Annual J.P. Morgan Healthcare Conference
2019-01-09    
10:30 am
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will be presenting at the 37th Annual J.P. Morgan Healthcare Conference in San [...]
International Conference on Chemistry, Chemical Engineering and Chemical Process
2019-01-30 - 2019-01-31    
All Day
It is a great pleasure and an honor to extend to you a warm invitation to attend the "International Conference on Chemistry, Chemical Engineering and [...]
Streamline HCP Workflow • Drive Patient Education • Navigate the Specialty Prescribing Landscape
2019-02-01    
12:00 am
The original and most comprehensive conference series dedicated entirely to strategies for effective utilization of e-Rx and EHR technologies is back for 2019. Whether new [...]
Latest News

NCH First U.S. Hospital to Use AI for Early Heart Attack Prediction

Naples Community Hospital (NCH) has set a new benchmark in U.S. healthcare by becoming the first hospital in the country to implement AI technology capable of detecting hidden heart attack risks up to 10 years in advance. Announced on November 5, 2025, this milestone highlights the growing influence of artificial intelligence in predictive medicine and hospital innovation.

Developed by Caristo Diagnostics, the AI platform applies deep learning algorithms to routine cardiac CT scans, identifying subtle early indicators of coronary disease—such as inflammation—often missed by traditional imaging. By detecting these risk factors long before symptoms appear, clinicians can deliver earlier interventions, personalized treatment plans, and improved patient outcomes, aligning with the shift toward value-based and preventive care.

For hospital administrators, this innovation delivers both clinical and financial benefits. Early detection can reduce emergency cardiac events, readmissions, and critical care costs, while strengthening NCH’s position as a leader in preventive cardiology. It also enhances partnerships with insurers and accountable care organizations focused on outcomes-based reimbursement and helps attract top cardiovascular talent and research collaborations.

The initiative was led by NCH’s clinical and IT teams in partnership with Caristo Diagnostics, focusing on workflow integration, staff training, and strong data governance to ensure compliance and patient safety. The AI system now supports risk assessment for patients undergoing routine cardiac imaging or preoperative evaluations, advancing NCH’s broader digital transformation strategy to improve efficiency and care quality.

From a procurement standpoint, NCH’s approach offers a model for other health systems exploring AI adoption—emphasizing vendor collaboration, performance-based pricing, and seamless integration with existing EHR and imaging systems.

This pioneering effort demonstrates how hospitals can leverage AI to transform population health management, meet new reimbursement models, and gain a competitive edge in digital cardiology. As more health systems observe NCH’s success, experts anticipate a surge in AI-driven innovation across diagnostics, monitoring, and care optimization throughout U.S. healthcare.